Mark Hannink
- Molecular Biology top 0.5%
- Immunology top 2%
- Cancer Research top 1%
- Cell Biology top 1%
- Epidemiology top 5%
- Co-authors
- Donna D. ZhangShih‐Ching LoJ. Alan DiehlDaniel J. DonoghueDonna ZhangDennis J. TempletonJanet V. CrossRandal J. Kaufman
- Topics
- Genomics, phytochemicals, and oxidative stress (22 papers)Virus-based gene therapy research (15 papers)NF-κB Signaling Pathways (13 papers)
- Partner nations
- United StatesGermanyIsrael
In The Last Decade
Mark Hannink
92 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 6.6k
- Immunology 1.2k
- Cancer Research 1.1k
- Cell Biology 1.1k
- Epidemiology 849
Countries citing papers authored by Mark Hannink
This map shows the geographic impact of Mark Hannink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hannink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hannink more than expected).
Fields of papers citing papers by Mark Hannink
This network shows the impact of papers produced by Mark Hannink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hannink. The network helps show where Mark Hannink may publish in the future.
Co-authorship network of co-authors of Mark Hannink
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hannink. A scholar is included among the top collaborators of Mark Hannink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hannink. Mark Hannink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 219 | |
| 6 | 38 | |
| 7 | 26 | |
| 8 | 12 | |
| 9 | 23 | |
| 10 | 51 | |
| 11 | 48 | |
| 12 | 30 | |
| 13 | 99 | |
| 14 | 44 | |
| 15 | 461 | |
| 16 | 16 | |
| 17 | 35 | |
| 18 | 191 | |
| 19 | 88 | |
| 20 | 11 |
About Mark Hannink
Mark Hannink is a scholar working on Molecular Biology, Cancer Research and Immunology, having authored 92 papers that have together received 9.0k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (22 papers), Virus-based gene therapy research (15 papers) and NF-κB Signaling Pathways (13 papers). The work is most often cited by research in Molecular Biology (6.6k citations), Cancer Research (1.1k citations) and Cell Biology (1.1k citations). Mark Hannink has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Donna D. Zhang, Shih‐Ching Lo, J. Alan Diehl, Daniel J. Donoghue, Donna Zhang, Dennis J. Templeton, Janet V. Cross, Randal J. Kaufman, Sara B. Cullinan and Edward Arvisais. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.